MedTrace Logo

Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study

NCT03573479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-02-24

No results posted yet for this study

Summary

This is a pilot quality improvement implementation study that will measure the impact of a rehabilitation bundle implementation on the outcomes of interest. Advancements in the care provided in Pediatric Intensive Care Units (PICUs) have led to fewer deaths in children. These improvements are unfortunately countered by the emergence of side effects of critical illness, known as PICU-acquired complications (PACs). Delirium, muscle weakness, drug dependency and withdrawal are increasingly common. PACs occur because children are often over-sedated and experience long periods of immobilization. PACs delay recovery, increase disability and worsen long-term function and quality-of-life. Although they are preventable, PACs are very common and frequently overlooked by clinicians. This study aims to "liberate"children from critical illness and improve their recovery and functioning after discharge, through an innovative rehabilitation bundle of 8 complementary steps (PICU Liber8) to reduce sedation, allow children to awaken and breathe comfortably, encourage early mobilization, and engage families in their child's care.

Conditions

  • Delirium
  • Withdrawal Syndrome
  • Hospital Acquired Condition
  • Critical Illness Myopathy
  • Critical Illness

Interventions

OTHER

PICU Liber8 Bundle

Bundle of elements for quality improvement

Sponsors & Collaborators

Principal Investigators

  • Karen Choong, MD, MSc · McMaster University

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2020-09-30
Completion
2020-10-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03573479 on ClinicalTrials.gov